Pseudoephedrine Use in POTS

Cardiovascular Effects

Pseudoephedrine causes a mean increase of 2.83 beats per minute in heart rate, which could theoretically worsen the excessive tachycardia already present in POTS, according to the American Academy of Allergy, Asthma, and Immunology 1, 2
The medication increases systolic blood pressure by approximately 0.99 mmHg on average, though individual variation exists, as reported by the American Academy of Allergy, Asthma, and Immunology 1, 2
Patients with arrhythmias should use alpha-adrenergic agonists like pseudoephedrine with caution, as recommended by the American Heart Association 1, 2
Uncontrolled hypertension is a relative contraindication for pseudoephedrine use, as stated by the American Heart Association 1, 2
Coronary artery disease or cerebrovascular disease warrants extreme caution with sympathomimetic agents like pseudoephedrine, according to the American College of Cardiology 1, 2

The American College of Cardiology recommends midodrine (2.5-10 mg) as a more studied vasoconstrictor for POTS, taken with the first dose in the morning before rising and the last dose no later than 4 pm 3
Beta-blockers show the largest reduction in heart rate variability, though they may worsen fatigue, as reported by the American College of Cardiology 3
Non-pharmacologic interventions like salt loading (5-10 g/day), fluid intake (3 liters/day), compression stockings, and exercise reconditioning remain foundational, according to the American College of Cardiology 3

Patients should be monitored for worsening tachycardia or development of palpitations, as these are already prominent symptoms in POTS, as recommended by the European Society of Cardiology 4
Monitoring for adverse effects including palpitations, tremor, irritability, and worsening orthostatic symptoms is necessary when using pseudoephedrine, as stated by the American Academy of Allergy, Asthma, and Immunology 1, 2
Combining pseudoephedrine with caffeine or other stimulants can have additive adverse cardiovascular effects, as warned by the American Academy of Allergy, Asthma, and Immunology 1

If pseudoephedrine is used in POTS, it is recommended to start with low doses and monitor heart rate and blood pressure response closely, as advised by the American College of Cardiology 3
Time dosing carefully to avoid worsening sleep disturbances, which are common in POTS, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

POTS is characterized by excessive orthostatic tachycardia (increase in heart rate by at least 30 beats per minute upon standing) without orthostatic hypotension, often accompanied by symptoms of orthostatic intolerance, as stated by the European Society of Cardiology 5, 6
Diagnosis requires an increase in heart rate ≥30 bpm (or ≥40 bpm in patients aged 12-19 years) within 10 minutes of standing or head-up tilt in the absence of orthostatic hypotension, according to the European Heart Journal 5, 6

Common symptoms of POTS include dizziness, light-headedness, weakness, fatigue, palpitations, tremor, generalized weakness, and blurred vision, as reported by the European Heart Journal 6, 7
The American College of Cardiology recommends considering compression garments, increased salt and fluid intake, and vasoconstrictors for patients with hypovolemic or neuropathic POTS 8